Nevada Medicaid and Nevada Check Up News (Third Quarter 2024 Provider Newsletter) [Read]

Attention Behavioral Health Providers: Monthly Behavioral Health Training Assistance (BHTA) Webinar Scheduled [See Web Announcement 2009]

Attention All Providers: Requirements on When to Use the National Provider Identifier (NPI) of an Ordering, Prescribing or Referring (OPR) Provider on Claims [Announcement 850]

If you are a Medicaid provider whose revalidation application has not been processed by your termination due date, you will be ineligible to provide services to any Nevada Medicaid or Nevada Check Up recipients, including both Fee-for-Service and Managed Care Organization (MCO) enrolled recipients. See Web Announcement 1265

Enrollment Termination Frequently Asked Questions (FAQs) [Review]

Notifications

NOTIFICATION: The following Nevada Medicaid Provider Web Portal services will be unavailable from 8 p.m. to midnight Pacific Time Sunday, December 22, 2024, for scheduled maintenance:
  • Secure Provider Web Portal (Electronic Verification System – EVS), which includes:
    • Recipient Eligibility
    • Provider Claim Appeals
    • Prior Authorization (PA) system
    • Claims Submission
  • Online Provider Enrollment (OPE)
  • Gabby®, which includes:
    • Customer Service Center (877) 638-3472
    • Automated Response System (ARS) (800) 942-6511
  • Real time CAQH/CORE EDI eligibility and claim verification
  • Provider PASRR

Unwinding COVID-19 Information

Known System Issues-Click HERE

Paper claims are no longer accepted by Nevada Medicaid. Please refer to Web Announcement 1733 and Web Announcement 1829 for additional information.

Top 10 Claim Denial Reasons and Resolutions/Workarounds for November 2024 Professional Claims. See Web Announcement 3509.

Top Enrollment Return Reasons and Resolutions for January 2024 Submissions. See Web Announcement 3350.

Top Prior Authorization Denial Reasons for the Third Quarter of 2024. See Web Announcement 3488.

Attention Providers Using the Authorization Criteria Function: Results that return prior authorization (PA) requirements are accurate. For results that return “There are no records found based on the search criteria,” there may be a PA requirement if limits have been exceeded. To verify PA requirements, please refer to the Medicaid Services Manual (MSM) Chapter for your service type at dhcfp.nv.gov and the Billing Guide for your provider type at www.medicaid.nv.gov.

Scheduled Site Maintenance

During the scheduled site maintenance window the Provider Web Portal will be unavailable. The table below shows the regularly scheduled maintenance window. All times will be in the Pacific time zone.

Monday - Friday
12:00AM - 12:30AM

Monday
8:00PM - 12:00AM

Notice Date Title
Oct. 31, 2013 For Review at December 19 Meeting: Anticonvulsants
Oct. 31, 2013 For Review at December 19 Meeting: Epinephrine for Anaphylaxis Agents
Oct. 31, 2013 For Review at December 19 Meeting: Incretin Mimetics
Oct. 31, 2013 For Review at December 19 Meeting: Inhaled Antimuscarinics
Oct. 31, 2013 For Review at December 19 Meeting: Long-acting Opioids
Oct. 31, 2013 For Review at December 19 Meeting: Multiple Sclerosis Agents
Oct. 31, 2013 For Review at December 19 Meeting: Ophthalmic Glaucoma Combinations
Aug. 12, 2013 For Review at September 26 Meeting: ADHD_Agents_and_Stimulants
Aug. 12, 2013 For Review at September 26 Meeting: Alpha_Glucosidase_Inhibitors
Aug. 12, 2013 For Review at September 26 Meeting: Alzheimer's_Agents
Aug. 12, 2013 For Review at September 26 Meeting: Amylin_Analogs
Aug. 12, 2013 For Review at September 26 Meeting: Antivirals:_Influenza
Aug. 12, 2013 For Review at September 26 Meeting: Beta_Agonists:_Single_Entity_Agents
Aug. 12, 2013 For Review at September 26 Meeting: Beta_Agonists:_Combination_Products
Aug. 12, 2013 For Review at September 26 Meeting: Bile_Acid_Sequestrants
Aug. 12, 2013 For Review at September 26 Meeting: Dipeptidyl_Peptidase-4_(DPP-4)_Inhibitors
Aug. 12, 2013 For Review at September 26 Meeting: Dopamine_Agonists
Aug. 12, 2013 For Review at September 26 Meeting: Epinephrine_for_Anaphylaxis_Agents
Aug. 12, 2013 For Review at September 26 Meeting: Fibric_Acid_Derivatives
Aug. 12, 2013 For Review at September 26 Meeting: Growth_Hormone
Aug. 12, 2013 For Review at September 26 Meeting: Hepatitis_C_Antivirals
Aug. 12, 2013 For Review at September 26 Meeting: Hepatitis_C_Protease_Inhibitors
Aug. 12, 2013 For Review at September 26 Meeting: HMG_CoA_Reductase_Inhibitors
Aug. 12, 2013 For Review at September 26 Meeting: Immunomodulators
Aug. 12, 2013 For Review at September 26 Meeting: Incretin_Mimetics
Aug. 12, 2013 For Review at September 26 Meeting: Inhaled_Antimuscarincs
Aug. 12, 2013 For Review at September 26 Meeting: Inhaled_Corticosteroids_(ICS)
Aug. 12, 2013 For Review at September 26 Meeting: Injectable_Anticoagulants
Aug. 12, 2013 For Review at September 26 Meeting: Intranasal_Antihistamines
Aug. 12, 2013 For Review at September 26 Meeting: Intranasal_Corticosteroids
Aug. 12, 2013 For Review at September 26 Meeting: Long-acting_Opioids
Aug. 12, 2013 For Review at September 26 Meeting: Meglitinides
Aug. 12, 2013 For Review at September 26 Meeting: Neuropathic_Pain_Agents
Aug. 12, 2013 For Review at September 26 Meeting: Ophthalmic_Antibiotics
Aug. 12, 2013 For Review at September 26 Meeting: Ophthalmic_Antihistamines
Aug. 12, 2013 For Review at September 26 Meeting: Ophthalmic_Nonsteroidal_Anti-Inflammatory_Drugs
Aug. 12, 2013 For Review at September 26 Meeting: Ophthalmic_Prostaglandin_Analogues
Aug. 12, 2013 For Review at September 26 Meeting: Oral_Anticoagulants
Aug. 12, 2013 For Review at September 26 Meeting: Oral_Antivirals:_Herpes
Aug. 12, 2013 For Review at September 26 Meeting: Oral_Atypical_Antipsychotics
Aug. 12, 2013 For Review at September 26 Meeting: Pancreatic_Enzymes
Aug. 12, 2013 For Review at September 26 Meeting: Pegylated_Interferons
Aug. 12, 2013 For Review at September 26 Meeting: Platelet_Inhibitors
Aug. 12, 2013 For Review at September 26 Meeting: Proton_Pump_Inhibitors
Aug. 12, 2013 For Review at September 26 Meeting: Scabicides_and_Pediculicides
Aug. 12, 2013 For Review at September 26 Meeting: Selective_Serotonin_(5-HT1)_Agonists
Aug. 12, 2013 For Review at September 26 Meeting: Sodium_Glucose_Co-transporters_2_Inhibitors
Aug. 12, 2013 For Review at September 26 Meeting: Topical_Androgens
Aug. 12, 2013 For Review at September 26 Meeting: Topical_Antivirals
Aug. 12, 2013 For Review at September 26 Meeting: Topical_Immunomodulators
Aug. 12, 2013 For Review at September 26 Meeting: Topical_Impetigo_Agents
Aug. 12, 2013 For Review at September 26 Meeting: Ulcerative_Colitis_Agents
Aug. 12, 2013 For Review at September 26 Meeting: Urinary_Antispasmodics
May 10, 2013 For Review at June 27 Meeting: ADHD Agents and Stimulants
May 10, 2013 For Review at June 27 Meeting: Alpha-Glucosidase Inhibitors
May 10, 2013 For Review at June 27 Meeting: Amylin Analogs
May 10, 2013 For Review at June 27 Meeting: Anticonvulsants
May 10, 2013 For Review at June 27 Meeting: Meglitinides
May 10, 2013 For Review at June 27 Meeting: Multiple Sclerosis Agents
May 10, 2013 For Review at June 27 Meeting: Selective Serotonin (5-HT1) Receptor Agonists
May 10, 2013 For Review at June 27 Meeting: Ulcerative Colitis Agents
May 10, 2013 For Review at June 27 Meeting: Urinary Antispasmodics
Feb. 6, 2013 For Review at March 28 Meeting: Bisphosphonates
Feb. 6, 2013 For Review at March 28 Meeting: Hepatitis C Antivirals
Feb. 6, 2013 For Review at March 28 Meeting: Inhaled Corticosteroids
Feb. 6, 2013 For Review at March 28 Meeting: Ophthalmic Steroids
Feb. 6, 2013 For Review at March 28 Meeting: Oral Anticoagulants
Feb. 6, 2013 For Review at March 28 Meeting: Oral Pulmonary Arterial Hypertension Agents

Return to Past Meeting Reports.